Back to results
US 2025/0360100 A1Published application
Anti-cancer derivatives of ovatodiolide and use thereof
AssigneeArjil Biotech Holding Company Limited
InventorsYeh B WU, On LEE, Hui Ju LIANG, Wan Hsu YANG
Life of this patent
Estimating the term…
Abstract
The present invention pertains to a new derivative of ovatodiolide, which has unexpectedly good cytotoxicity in cancer cells. Also provided are the preparation process and the use of the new derivative of ovatodiolide.
Claims9
A compound Ova-Oxy having a chemical structure selected from the four structures below:
Dependencies are inferred from the claim text.